Related Experiment Video
Updated: Jun 8, 2026
12:15
Image Processing Protocol for the Analysis of the Diffusion and Cluster Size of Membrane Receptors by Fluorescence Microscopy
Published on: April 9, 2019
Sizing nanomatter in biological fluids by fluorescence single particle tracking
Kevin Braeckmans1, Kevin Buyens, Wim Bouquet
1Laboratory of General Biochemistry and Physical Pharmacy, Ghent University, Harelbekestraat 72, 9000 Gent, Belgium.
Nano Letters
|October 7, 2010
Summary
Accurate nanoparticle sizing is crucial for drug delivery and imaging. This study prevented nanoparticle aggregation in blood circulation using surface functionalization, ensuring effective in vivo performance.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Pharmacology
Background:
- Accurate nanoparticle sizing in biological media is critical for effective drug delivery and biomedical imaging.
- Nanoparticle size influences in vivo processing, biodistribution, and potential nanotoxicity.
Purpose of the Study:
- To investigate nanoparticle aggregation in real-time within undiluted whole blood.
- To evaluate the efficacy of surface functionalization in preventing nanoparticle aggregation during circulation.
Main Methods:
- Utilized fluorescence single particle tracking (fSPT) for real-time monitoring.
- Observed drug delivery nanoparticles in undiluted whole blood.
Main Results:
- Successfully tracked nanoparticle aggregation dynamics in real-time.
- Demonstrated that appropriate surface functionalization significantly inhibits nanoparticle aggregation in blood circulation.
Conclusions:
- Surface functionalization is a key strategy to control nanoparticle behavior in vivo.
- Preventing aggregation enhances the safety and efficacy of nanoparticles for biomedical applications.
